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Animals whose sex is determined by different combina-
tions of sex chromosomes face something of a paradox.
The embryo must be able to distinguish between two
alternative karyotypes in order to initiate the appropriate
sexual differentiation. In most such animals, however, the
differences between these karyotypes must be
compensated for to ensure that non-sex-determining
genes on the sex chromosomes are expressed at similar
levels in the two sexes. Mammals such as ourselves, with
XX female / XY male sex determination, solve this
problem by separating it into two. Sex is determined inde-
pendently of the number of X chromosomes by the pres-
ence or absence of a Y chromosome, which carries few
genes with functions other than sex determination and
male sexual differentiation. X chromosome dosage com-
pensation is accomplished by effectively shutting down
one or the other X chromosome in every cell of an early
female embryo, by a mechanism that persists through
subsequent cell generations and is irreversible in most
tissues throughout life [1].
For invertebrates, such as the fruitfly Drosophila and the
nematode Caenorhabditis elegans, in which sex is deter-
mined only by the number of X chromosomes — actually
the X:A ratio of X chromosomes to sets of autosomes —
the problem is trickier because sex must be determined
by the same karyotypic difference that dosage com-
pensation is designed to counteract. In flies, females are
XX and males XY, but the Y chromosome plays no role in
sex determination. In worms, hermaphrodites are XX
and males XO. In each of these organisms, the problem
posed above is solved by somewhat mind-boggling
pathways of interacting regulatory genes, similar in
complexity but different in mechanism, which coordi-
nately control the effectors of sex determination and
dosage compensation.
In the fly and the worm, both sex determination and
dosage compensation are under the control of a master
regulatory gene on the X chromosome which is differen-
tially activated in the two sexes according to the copy
number of several other X-linked loci, known as numera-
tor elements. Quite a lot is now known about the mecha-
nism of this initial decision in flies, less in worms [2]. But
now the logic, and some of the molecular functions, of the
worm’s regulatory apparatus, replete with branches, feed-
forward and feedback loops, have become clear, due
almost entirely to the work of Barbara Meyer and her col-
leagues, following earlier elucidation of the sex-determi-
nation pathway per se by Jonathan Hodgkin [3]. 
Dosage compensation in C. elegans is accomplished by
down-regulating X chromosome gene expression in XX
animals: not by inactivating one X, as in mammals, but
rather by globally repressing expression of the genes on
both X chromosomes by a factor of two relative to their
expression level in XO animals [4,5]. This chromosome-
wide modulation must be superimposed on the various
gene-specific controls that regulate X-linked genes during
development. 
The model pathway for regulation of dosage compensa-
tion and its relationship to sex determination, shown in
Figure 1, is based on a series of incisive genetic analyses
by Meyer and colleagues between 1987 and 1995
(reviewed in [2]). The results suggested that xol-1 (for XO
lethal), which is activated specifically in XO animals, neg-
atively regulates each of three sdc (sex determination and
dosage compensation) genes. These in turn negatively
regulate the first gene in the sex-determination pathway,
Figure 1
Proposed pathway of regulatory gene interactions for the control of sex
determination and dosage compensation in C. elegans (some
suggested regulatory loops have been omitted). The sdc genes act to
repress her-1 expression and activate dpy genes; dpy-30 is now
thought to act further upstream in the pathway (see Fig. 2).
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her-1, and also positively regulate a group of four ‘dumpy’
genes, dpy-21, dpy-26, dpy-27 and dpy-28, which were
thought to be effectors of dosage compensation; a fifth dpy
gene, dpy-30, is regulated separately. 
Loss-of-function mutations in xol or the sdc or dpy genes
cause inappropriate dosage compensation, resulting in
sex-specific lethality. As should be clear from Figure 1,
xol-1 mutations kill (and feminize) XO animals because
the sdc genes are inappropriately activated, repressing
her-1 and X-linked genes; whereas sdc mutations kill (and
masculinize) XX animals, because of the inappropriate
lack of repression of her-1 and X-linked genes. Mutations
in most of the dpy genes also cause maternal-effect XX
lethality (without sexual transformation), because of a
failure of dosage compensation, or extreme ‘dumpiness’, a
consequence of overexpression of X-linked genes, in the
homozygous mutant XX progeny of a heterozygous her-
maphrodite. Furthermore, dpy-26 and dpy-28 mutations
cause a low level of generalized chromosome non-disjunc-
tion during meiosis.
What are the proteins encoded by these genes and how
might they function? Earlier molecular analyses provided
structural information, but little insight into their mecha-
nisms of action. The xol-1 gene, controlled at the level of
transcript accumulation, is predicted to encode a novel
protein of 425 amino acids, with an acidic carboxyl termi-
nus, which is required for sdc regulation [6]. SDC-1 and
SDC-3 are maternally and embryonically synthesized pro-
teins that are present in both sexes. SDC-1, a large protein
of 1203 amino acids, includes seven zinc-finger motifs [7],
and SDC-3 has two mutationally separable domains near
the carboxyl terminus: one includes a zinc-finger motif
and is required for dosage compensation; the other
includes a myosin-like putative ATP-binding region and
is required for her-1 regulation in sex determination. A
third, more amino-terminal, domain of SDC-3 is also
required for dosage compensation [8]. SDC-2, made only
in XX animals, is a novel protein of 350 kD with no known
sequence motifs [2,9]. DPY-30 is a small, novel and ubiq-
uitously expressed nuclear protein that is thought to
enhance SDC-3 function, as well as serving other, more
general roles in development [10,11]. 
Recent molecular analyses of other dpy genes have pro-
vided clues to how the dosage-compensation process
works. A breakthrough came in 1994, when the dpy-27
gene was cloned and predicted to encode a protein of the
SMC1 (structural maintenance of chromosomes) class
[12], defined by chromosomal proteins from yeast [13] and
vertebrates [14]. In both XX and XO pre-gastrulation
embryos, DPY-27 was detected as diffuse immunostaining
in all somatic nuclei. In XX embryos, after the onset of
gastrulation, when dosage compensation is thought to be
initiated, DPY-27 was seen to associate specifically with X
chromosomes during all stages of the cell cycle. In XO
embryos, DPY-27 staining remained diffuse; X-chromo-
some-specific association of DPY-27 was seen, however, in
non-viable xol-1 mutant XO embryos, which die because
of inappropriate activation of the dosage-compensation
machinery. 
In two recent Science papers [15,16], Meyer and colleagues
have reported analysis of another dpy gene, and evidence
that the DPY proteins form a complex required for dosage
compensation. DPY-26, a novel protein that is also made
from early embryogenesis onward, differs from DPY-27 in
that, before gastrulation, it associates with all chromo-
somes during mitosis. Thereafter, DPY-26 associates only
with X chromosomes throughout the cell cycle, in XX
embryos but not XO embryos unless they are mutant for
xol-1. The X-chromosome-specific association of DPY-26
depends on DPY-27, and vice versa; for both proteins, the
specific association also depends on the functions of sdc-2,
sdc-3, dpy-28 and dpy-30. The stabilities — or, less likely,
the translation — of the two proteins are also mutually
interdependent, and the function of the dpy-28 gene,
which has not yet been cloned, is required for the stability
of both proteins. DPY-26 also differs from DPY-27 in that
it is present in the adult hermaphrodite germ line, where
it associates with all meiotic chromosomes, consistent with
the above-mentioned requirement for dpy-26 function to
assure the fidelity of meiotic segregation. The stability of
DPY-26 in the germ line depends on dpy-28 function, but,
in contrast to its role in embryonic dosage compensation,
its chromosomal association does not depend on sdc-2,
sdc-3, dpy-27 or dpy-30.
These results suggested that DPY-26 might act in a
complex with DPY-27, as well as DPY-28, on the X chro-
mosome to mediate dosage compensation in the embryo,
and possibly in a different complex, this time without
DPY-27, to mediate meiotic chromosome segregation in
the germ line. Direct evidence for the first complex was
obtained by immunoprecipitating both DPY-26 and DPY-
27 proteins from embryonic nuclear extracts with either
anti-DPY-26 or anti-DPY-27 antibodies. At least two other
proteins coprecipitated with DPY-26 and DPY-27, one of
which was postulated to be the still uncharacterized DPY-
28 [15]. Although no evidence for this was reported, the
complex presumably also forms in the nuclei of XO
animals, but in this case does not associate specifically
with the X chromosome.
Davis and Meyer [11] have now found that the SDC-3
protein is also directly involved in chromosome modifica-
tion. Like DPY-26 and DPY-27, SDC-3 also associates
specifically with the X chromosome in XX embryos. This
association requires the functions of sdc-2, dpy-26, dpy-27,
dpy-28 and dpy-30; the latter three genes are also required
for the stability (or translation) of SDC-3. The authors
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present evidence that both the zinc-finger and amino-ter-
minal dosage-compensation domains of SDC-3 are
required for its association with the X chromosome: they
suggest that the former may be involved in X-chromo-
some recognition and the latter in interactions with other
components of the complex. 
Interestingly, the functions of sdc-1 and dpy-21 are not
required for the X-chromosome association or stability of
either DPY-26, DPY-27 or SDC-3, suggesting they play
other roles in dosage compensation. And finally, a piece of
the puzzle missing so far has been the function of the
novel protein SDC-2, which has been the prime candidate
for dictating the sex specificity of X-chromosome associa-
tion, because it is the only one of the required gene prod-
ucts that is produced only in XX animals. In recent work
(cited in [2]), SDC-2 also has been found to associate with
the X chromosomes in XX embryos, suggesting that it
may initiate formation of the regulatory complex. 
In summary, C. elegans appears to accomplish dosage
compensation by a change in X chromosome structure that
reduces expression of X-linked genes by a factor of two in
XX, relative to XO, animals. To do so, C. elegans has
evolved a sex-specific mechanism for targeting to the her-
maphrodite X chromosomes a regulatory protein complex,
which includes proteins that are also likely to play roles in
chromosome segregation. Dosage compensation in C.
elegans thus provides another example of a specific devel-
opmental process for which housekeeping proteins have
been recruited and modified. Chro-
mosomal proteins involved in both
chromosome segregation and global
transcriptional control are not new:
such dual functions are exhibited, for
example, by the heterochromatin-
binding protein HP1 in Drosophila
[17] and the Swi6 protein in fission
yeast [18]. Not surprisingly, both
these processes can be affected by
changes in chromatin structure. 
The emerging picture of the dosage-
compensation machinery in C. elegans
(Fig. 2) raises several questions that are
now ripe for answering. First, what are
the roles of sdc-1 and dpy-21? Second,
as known SMC1 proteins function as
heterodimers with a related protein of
the SMC2 class, could there be an
SMC2 homologue that is also part of
the complex, perhaps the product of
dpy-28 or an as yet unidentified gene?
Third, does association of DPY-26 with
all mitotic chromosomes in somatic
nuclei of pregastrulation embryos play
a role in directing mitotic chromosome segregation, or does
this association simply serve to stabilize and distribute
DPY-26 uniformly to all somatic cells in preparation for
later dosage compensation? No defects in mitotic segrega-
tion resulting from mutations in dpy genes have been
reported, and in XX embryos, at any rate, postgastrulation
segregation of autosomes clearly must proceed without
DPY-26. DPY-27 does not associate with mitotic chromo-
somes — could there be an additional SMC1 homologue
that takes its place? Fourth, is there dosage compensation
in the germ line, and if so, how is it accomplished in the
absence of DPY-27? Fifth and last, how does DPY-26 act in
its quite distinct role of directing meiotic segregation in the
germ line? Does it have other partners, perhaps including
other germ-line-specific homologues of the SMC proteins?
The tools are available to address most of these questions,
and more answers should soon be forthcoming.
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Figure 2
A model for sex-specific control of dosage compensation in C. elegans by the sdc and dpy gene
products. (Modified from [2].)
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